What is the recommended dosage of cefdinir (Cephalosporin antibiotic) for a 19-month-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosage for a 19-Month-Old Child

The recommended dosage of cefdinir for a 19-month-old child is 14 mg/kg/day, which can be administered as a single daily dose or divided into two doses (7 mg/kg twice daily). 1

Dosing Guidelines Based on FDA Label

  • The FDA-approved dosage for cefdinir in pediatric patients aged 6 months through 12 years is 14 mg/kg/day, up to a maximum dose of 600 mg per day 1
  • For most infections, cefdinir can be administered as:
    • 14 mg/kg once daily (q24h), OR
    • 7 mg/kg twice daily (q12h) 1
  • The duration of treatment depends on the type of infection:
    • Acute bacterial otitis media: 5-10 days (once daily) or 10 days (twice daily) 1
    • Acute maxillary sinusitis: 10 days 1
    • Pharyngitis/tonsillitis: 5-10 days (once daily) or 10 days (twice daily) 1
    • Uncomplicated skin and skin structure infections: 10 days (must be given twice daily) 1

Practical Administration

  • For a 19-month-old child, cefdinir is available as an oral suspension in two concentrations:
    • 125 mg/5 mL
    • 250 mg/5 mL 1
  • The dose should be calculated based on the child's weight:
    • For example, if the child weighs approximately 11-12 kg, the daily dose would be around 154-168 mg 1
    • This could be given as 77-84 mg twice daily or 154-168 mg once daily 1

Clinical Efficacy and Safety

  • Cefdinir has demonstrated good clinical and bacteriological efficacy in the treatment of various pediatric infections including respiratory tract and skin infections 2
  • It provides good coverage against common pediatric pathogens including Haemophilus influenzae, Moraxella catarrhalis, and penicillin-susceptible Streptococcus pneumoniae 2
  • The drug is stable to hydrolysis by commonly occurring plasmid-mediated beta-lactamases and retains good activity against beta-lactamase-producing strains 2

Administration Considerations

  • Cefdinir oral suspension can be administered without regard to meals 1
  • After reconstitution, the suspension can be stored at room temperature (25°C/77°F) 1
  • The container should be kept tightly closed, and the suspension should be shaken well before each administration 1
  • The suspension may be used for 10 days, after which any unused portion must be discarded 1

Special Considerations

  • For pediatric patients with renal insufficiency (creatinine clearance <30 mL/min/1.73 m²), the dose should be reduced to 7 mg/kg given once daily 1
  • For patients on hemodialysis, the recommended dosage is 7 mg/kg every other day, with an additional dose after each hemodialysis session 1
  • The most common adverse event reported in pediatric patients is diarrhea 2, 3

Comparative Efficacy

  • In clinical studies, cefdinir has shown efficacy comparable to other antibiotics commonly used in pediatric patients 4
  • For skin infections, cefdinir (7 mg/kg twice daily) demonstrated clinical cure rates of 98.3% compared to 93.8% with cephalexin (10 mg/kg four times daily) 3
  • The convenient once- or twice-daily dosing of cefdinir may offer advantages over antibiotics requiring more frequent administration 4

Remember to adjust the dose based on the child's exact weight and the specific infection being treated, and to complete the full course of treatment as prescribed.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.